Education
About Us
Working with TipRanks
Follow Us
Britannia Life Sciences Inc (TSE:BLAB)
:BLAB
RESEARCH TOOLSreports
Total Valuation
Britannia Life Sciences Inc has a market cap or net worth of C$9.74M. The enterprise value is C$21.21M.
Market CapC$9.74M
Enterprise ValueC$21.21M
Share Statistics
Britannia Life Sciences Inc has 162,254,330 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding162,254,330
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Britannia Life Sciences Inc’s return on equity (ROE) is -1.96 and return on invested capital (ROIC) is 1.22%.
Return on Equity (ROE)-1.96
Return on Assets (ROA)-0.21
Return on Invested Capital (ROIC)1.22%
Return on Capital Employed (ROCE)0.01
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.34
Inventory Turnover14.73
Valuation Ratios
The current PE Ratio of Britannia Life Sciences Inc is -2.38. Britannia Life Sciences Inc’s PEG ratio is -0.02.
PE Ratio-2.38
PS Ratio0.00
PB Ratio2.19
Price to Fair Value4.66
Price to FCF17.62
Price to Operating Cash Flow12.66
PEG Ratio-0.02
Income Statement
In the last 12 months, Britannia Life Sciences Inc had revenue of 7.57M and earned -4.77M in profits. Earnings per share was -0.03.
Revenue7.57M
Gross Profit4.85M
Operating Income173.00K
Pretax Income-4.47M
Net Income-4.77M
EBITDA-1.90M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was 1.11M and capital expenditures -460.23K, giving a free cash flow of 654.30K billion.
Operating Cash Flow1.11M
Free Cash Flow654.30K
Free Cash Flow per Share<0.01
Dividends & Yields
Britannia Life Sciences Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.84
52-Week Price Change0.00%
50-Day Moving Average0.07
200-Day Moving Average0.06
Relative Strength Index (RSI)41.42
Average Volume (3m)55.21K
Important Dates
Britannia Life Sciences Inc upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.
Last Earnings DateMar 3, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend Date―
Financial Position
Britannia Life Sciences Inc as a current ratio of 0.26, with Debt / Equity ratio of 119.72%
Current Ratio0.26
Quick Ratio0.24
Debt to Market Cap0.61
Net Debt to EBITDA-3.15
Interest Coverage Ratio0.13
Taxes
In the past 12 months, Britannia Life Sciences Inc has paid -67.36K in taxes.
Income Tax-67.36K
Effective Tax Rate0.02
Enterprise Valuation
Britannia Life Sciences Inc EV to EBITDA ratio is -9.13, with an EV/FCF ratio of 9.88.
EV to Sales2.29
EV to EBITDA-9.13
EV to Free Cash Flow9.88
EV to Operating Cash Flow8.28
Balance Sheet
Britannia Life Sciences Inc has C$990.37K in cash and marketable securities with C$7.11M in debt, giving a net cash position of C$6.12M billion.
Cash & Marketable SecuritiesC$990.37K
Total DebtC$7.11M
Net CashC$6.12M
Net Cash Per ShareC$0.04
Tangible Book Value Per Share-C$0.07
Margins
Gross margin is 72.43%, with operating margin of 2.29%, and net profit margin of -62.99%.
Gross Margin72.43%
Operating Margin2.29%
Pretax Margin-59.00%
Net Profit Margin-62.99%
EBITDA Margin-25.05%
EBIT Margin-29.39%
Analyst Forecast
The average price target for Britannia Life Sciences Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-3.93%
EPS Growth Forecast-575.24%